The research project Screen4Care aims to tackle the major hurdle for rare disease patients – the lengthy and convoluted diagnosis journey – via an innovative research approach based on two central pillars: genetic newborn screening and artificial intelligence (AI)-based tools.
Screen4Care has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 101034427. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
www.imi.europa.eu
The communication here reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Brussels, Be
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://screen4care.eu/
- HQ
- Brussels
- Competitors
- NEWBORN SCREENING LAB, Osservatorio Malattie Rare, International Consortium on Newborn Sequencing (ICoNS), EURORDIS-Rare Diseases Europe, Innovative Health Initiative (IHI), Epilepsia Journal, International Society for Pediatric and Adolescent Diabetes (ISPAD), Illumina, Revvity, Journal of Inherited Metabolic Disease.
Screen4care Questions
Screen4Care's website is http://screen4care.eu/
Screen4Care's LinkedIn profile is https://be.linkedin.com/company/screen4care
Screen4Care has
2 employees.
View email and phone details for 2
employees at Screen4Care.
Screen4Care's industry is
Research Services
Screen4Care's top competitors are
Newborn Screening Lab,
Osservatorio Malattie Rare,
International Consortium On Newborn Sequencing (Icons),
Eurordis-Rare Diseases Europe,
Innovative Health Initiative (Ihi),
Epilepsia Journal,
International Society For Pediatric And Adolescent Diabetes (Ispad),
Illumina,
Revvity,
Journal Of Inherited Metabolic Disease.
Screen4Care's categories are Research Services
Screen4Care's founding year is 2021
